Diagnostic application of immunoperoxidase monolayer assay using monoclonal antibodies produced against equine arteritis virus 14-kDa nucleocapsid protein.

This research article details the production of two monoclonal antibodies to tackle equine arteritis virus (EAV) in horses. Using a technique called immunoperoxidase monolayer assay, the antibodies demonstrated high affinity and specificity to the virus, opening up potential diagnostic applications.

Production of Monoclonal Antibodies

• The research focused on producing two monoclonal antibodies targeted against the equine arteritis virus (EAV). This virus is a significant threat to horse populations.
• The antibodies were produced against a specific strain of the virus, the Bucyrus strain.
• The antibodies recognized and reacted with the nucleocapsid (N) protein antigen found in the virus. This protein is a prominent feature of the virus and a critical component in its structure.

Effectiveness of the Antibodies

• The antibodies demonstrated high affinity and specificity to the virus antigen, forming the basis for their effectiveness.
• Each antibody reacted with different subtypes of EAV, indicating that they could be employed as a general tool for fighting off various forms of the virus.

Diagnostic Potential

• The researchers used an immunoperoxidase monolayer assay (IPMA) to assess the antibodies’ effectiveness, suggesting that this method can be used to diagnose EAV infection.
• By watching the interactions between the antibodies and the virus, researchers can understand whether an infection is present, and what subtype of the virus is causing it.

Further Analysis

• The researchers further analyzed the isotypes of the antibodies using an Ouchterlony immune diffusion assay.
• This further analysis identified the light chains as the kappaisotype and the heavy chains as the IgG 1 isotype, which can provide further information on the structure and function of the antibodies.